Molecular Investigations of Protriptyline as a Multi-Target Directed Ligand in Alzheimer's Disease
Figure 6
Protriptyline inhibits glycation.
A. Fluorescence emmission of Aβ and glycated Aβ in presence of various concentration of protriptyline B. Light scattering and C. Kinetics of amyloid aggregation by Thioflavin T of Aβ13–22 and glycated Aβ13–22 in the absence and presence of protriptyline.